SCHAFFER DERACE L 4
4 · Altimmune, Inc. · Filed Dec 27, 2017
Insider Transaction Report
Form 4
SCHAFFER DERACE L
Director
Transactions
- Purchase
Common Stock, par value $0.0001
2017-12-22$1.61/sh+17,982$28,877→ 362,895 total - Purchase
Common Stock, par value $0.0001
2017-12-27$1.76/sh+50,000$88,170→ 464,337 total - Purchase
Common Stock, par value $0.0001
2017-12-26$1.81/sh+51,442$93,269→ 414,337 total - Purchase
Common Stock, par value $0.0001
2017-12-27$1.77/sh+27,706$49,040→ 492,043 total
Holdings
- 12,393(indirect: By IRA)
Common Stock, par value $0.0001
Footnotes (3)
- [F1]The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $1.52 to $1.68 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price.
- [F2]The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $1.64 to $1.99 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price.
- [F3]The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $1.738075 to $1.77 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price.